See the best of our print edition with the 2024 cover story roundup
Our top 10 print stories highlight the core content concepts we explored this year
European Medicines Agency will assess semaglutide for link to NAION
The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition
Shining new light on ocular surface care
Low-level light therapy for dry eye disease and chalazion
A history of the femtosecond laser in the United States and Europe
The timeline demonstrates international innovation and collaboration
Balancing the promises and challenges of artificial intelligence
Sophisticated programmes require an evolving mindset
EssilorLuxottica announces agreement for acquisition of Espansione Group
Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology
A neurologist shares his warning about recurrent optic neuritis attacks and NMOSD
Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)
EMA CHMP issues positive opinion for aflibercept biosimilar, two other candidates from Celltrion
The European Commission will assess the marketing authorisation for Eydenzelt (reference product Eylea)
Putting diagnostic accuracy to the test
A confirmed diagnosis of familial exudative vitreoretinopathy aids in several aspects of patient management
European Medicines Agency approves faricimab (Vabysmo) 6.0 mg single-dose prefilled syringe
The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion
AMD-HALT programme receives Eurostars grant for continued investigation of dry AMD gene therapy platform
Phenocell and Amarna Therapeutics were awarded the grant by Eureka’s Eurostars initiative, co-funded by the European Union
Investigators report findings on serum inflammatory biomarkers in patients with macular oedema
A retrospective study assessed elevated neutrophil-to-lymphocyte ratios and systemic immune-inflammation index levels in patients with different subtypes of DMO
Myopia control study demonstrates 4-year results of Diffusion Optics Technology
The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children
Diabetic eye disease: Where are we now?
Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications
Case report: retinopathy associated with the use of hair dye aromatic amines
Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy
Industry updates from Floretina ICOOR 2024
The annual meeting brought fourth announcements and insights from companies in the retina care space
Charles Wykoff, MD, PhD, presents on diabetic retinopathy and "the dream of reperfusion" at Floretina ICOOR 2024
Dr Wykoff addressed the top three questions retina specialists have about retinal non-perfusion
Don’t miss our editorial advisory board members at the Floretina/ICOOR meeting
EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence
New wet AMD therapeutics seek to improve visual outcomes beyond the current standard of care
Breakthrough technologies are raising the ceiling for functional visual outcomes
The Floretina ICOOR meeting begins in Florence, Italy
What to expect from 4 days in the Fortezza de Basso
Adapting our understanding of cerebral visual impairment
The differential recruitment of the dorsal and ventral visual streams
Ethnic background has an impact on glaucoma outcomes
Gauging patient perceptions in an ethnically diverse UK cohort
Recyclable ophthalmic instrument company HASA OPTIX receives B Corporation certification
The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries
Factors of ocular pain and dry eye disease associated with anxiety and COVID-19
The authors analysed severity and frequency of ocular pain among patients with DED living in altitudes above 2,500 meters during the COVID-19 pandemic
New study examines RNFL changes and association with BMI, tobacco and alcohol use
A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss
The deep dish on all things ophthalmology at this year's AAO meeting
The annual meeting held in Chicago, Illinois, featured new data and best practices for patient-centred care
EMA grants orphan medicinal product designation for OCU410ST (Ocugen)
OCU410ST is indicated for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa and cone-rod dystrophy 3 (CORD3)
Ocular tuberculosis and relapse rates for recurrence of uveitis
Uveitic relapses primarily manifest as anterior uveitis, the authors said
On the 75th anniversary of the IOL, modern surgeons pay tribute
At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation
Arctic Vision partners with Santen Pharmaceutical Co., Ltd. to commercialise ARVN001 in China
ARVN001 is indicated for the treatment of uveitic macular oedema and certain other ophthalmic indications
